BRPI0907228A2 - Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos - Google Patents
Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usosInfo
- Publication number
- BRPI0907228A2 BRPI0907228A2 BRPI0907228-4A BRPI0907228A BRPI0907228A2 BR PI0907228 A2 BRPI0907228 A2 BR PI0907228A2 BR PI0907228 A BRPI0907228 A BR PI0907228A BR PI0907228 A2 BRPI0907228 A2 BR PI0907228A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparations
- pharmaceutical compositions
- thienopyridazine
- compounds
- thienopyridazine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810000936 | 2008-01-08 | ||
| CN200810000936.9 | 2008-01-08 | ||
| CN2009100003371A CN101481380B (zh) | 2008-01-08 | 2009-01-06 | 噻吩并哒嗪类化合物及其制备方法、药物组合物及其用途 |
| CN200910000337.1 | 2009-01-06 | ||
| PCT/CN2009/000021 WO2009092278A1 (zh) | 2008-01-08 | 2009-01-07 | 噻吩并哒嗪类化合物及其制备方法、药物组合物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0907228A2 true BRPI0907228A2 (pt) | 2015-07-14 |
| BRPI0907228B1 BRPI0907228B1 (pt) | 2021-08-03 |
Family
ID=40878690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907228-4A BRPI0907228B1 (pt) | 2008-01-08 | 2009-01-07 | Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8318740B2 (pt) |
| EP (1) | EP2241569B1 (pt) |
| JP (1) | JP5456694B2 (pt) |
| KR (1) | KR101512530B1 (pt) |
| CN (1) | CN101481380B (pt) |
| AU (1) | AU2009207968B2 (pt) |
| BR (1) | BRPI0907228B1 (pt) |
| CA (1) | CA2711629C (pt) |
| MX (1) | MX2010007502A (pt) |
| RU (1) | RU2494103C2 (pt) |
| WO (1) | WO2009092278A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2774367C (en) | 2009-09-18 | 2018-07-10 | Zhanggui Wu | Compounds and therapeutic use thereof for protein kinase inhibition |
| KR20160007598A (ko) | 2013-05-10 | 2016-01-20 | 님버스 아폴로, 인코포레이티드 | Acc 억제제 및 이의 용도 |
| MX2015015422A (es) | 2013-05-10 | 2016-06-21 | Nimbus Apollo Inc | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. |
| BR112015028214A2 (pt) | 2013-05-10 | 2017-07-25 | Nimbus Apollo Inc | inibidores de acc e usos dos mesmos |
| EA030958B1 (ru) | 2013-05-10 | 2018-10-31 | Джилид Аполло, Ллс | Ингибиторы акк и их применение |
| DK3013337T3 (en) | 2013-06-26 | 2019-02-25 | Abbvie Inc | PRIMARY CARBOXAMIDES AS BTK INHIBITORS |
| CN103288614B (zh) * | 2013-06-27 | 2014-09-17 | 中国科学院昆明植物研究所 | 具有抗肿瘤活性的间苯三酚类化合物及其药物组合物 |
| US9974774B2 (en) | 2013-07-26 | 2018-05-22 | Race Oncology Ltd. | Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof |
| CN103694217A (zh) * | 2013-12-20 | 2014-04-02 | 华东师范大学 | 一种2,4-二取代噻吩衍生物及其制备方法和应用 |
| EP4087561A4 (en) * | 2020-01-07 | 2024-02-14 | Shanghai Huayu Biotechnology Co Ltd | COMBINATION CANCER THERAPY WITH CHK INHIBITOR |
| US20230183259A1 (en) * | 2020-04-17 | 2023-06-15 | Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory | Crystal Form Of Thiofuran Pyridazine Compound, Preparation Method Therefor And Application Thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP2000000070A (es) * | 1999-09-28 | 2002-02-28 | Bayer Healthcare Llc | Piridinas y piridacinas sustituidas con actividad de inhibición de angiogénesis |
| JP2007502308A (ja) * | 2003-08-15 | 2007-02-08 | アストラゼネカ アクチボラグ | 置換チオフェンとその使用 |
| CA2552050C (en) * | 2004-01-05 | 2011-08-09 | Astrazeneca Ab | Substituted heterocycles and the uses thereof |
| EP1745051A1 (en) * | 2004-05-04 | 2007-01-24 | F.Hoffmann-La Roche Ag | Thienopyridazines as ikk inhibitors |
| RU2007140734A (ru) * | 2005-04-06 | 2009-05-20 | Астразенека Аб (Se) | Замещенные гетероциклы и их применение в качестве ингибиторов chki, pdki и pak |
| CA2649543A1 (en) * | 2006-04-21 | 2007-11-01 | Amgen Inc. | Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use |
| CN101687882A (zh) * | 2007-04-25 | 2010-03-31 | 百时美施贵宝公司 | 非碱性黑色素浓集激素受体-1拮抗剂 |
| US8273890B2 (en) * | 2007-06-29 | 2012-09-25 | 4Sc Ag | Thiophene-imidazopyridines |
-
2009
- 2009-01-06 CN CN2009100003371A patent/CN101481380B/zh active Active
- 2009-01-07 WO PCT/CN2009/000021 patent/WO2009092278A1/zh active Application Filing
- 2009-01-07 MX MX2010007502A patent/MX2010007502A/es active IP Right Grant
- 2009-01-07 AU AU2009207968A patent/AU2009207968B2/en active Active
- 2009-01-07 US US12/349,888 patent/US8318740B2/en active Active
- 2009-01-07 US US12/811,898 patent/US8962626B2/en active Active
- 2009-01-07 CA CA2711629A patent/CA2711629C/en active Active
- 2009-01-07 EP EP09703313A patent/EP2241569B1/en active Active
- 2009-01-07 JP JP2010541010A patent/JP5456694B2/ja active Active
- 2009-01-07 BR BRPI0907228-4A patent/BRPI0907228B1/pt active IP Right Grant
- 2009-01-07 KR KR1020107017631A patent/KR101512530B1/ko active IP Right Grant
- 2009-01-07 RU RU2010128221/04A patent/RU2494103C2/ru active
-
2012
- 2012-11-02 US US13/668,197 patent/US9249154B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9249154B2 (en) | 2016-02-02 |
| US20110009415A1 (en) | 2011-01-13 |
| EP2241569B1 (en) | 2012-05-23 |
| CA2711629A1 (en) | 2009-07-30 |
| US20090275585A1 (en) | 2009-11-05 |
| AU2009207968B2 (en) | 2014-04-24 |
| MX2010007502A (es) | 2010-10-15 |
| RU2010128221A (ru) | 2012-02-20 |
| AU2009207968A1 (en) | 2009-07-30 |
| KR20100117069A (ko) | 2010-11-02 |
| US20130143887A1 (en) | 2013-06-06 |
| EP2241569A4 (en) | 2011-01-12 |
| EP2241569A1 (en) | 2010-10-20 |
| CN101481380A (zh) | 2009-07-15 |
| JP2011508750A (ja) | 2011-03-17 |
| CN101481380B (zh) | 2012-10-17 |
| WO2009092278A1 (zh) | 2009-07-30 |
| KR101512530B1 (ko) | 2015-04-15 |
| US8318740B2 (en) | 2012-11-27 |
| WO2009092278A8 (zh) | 2010-07-22 |
| BRPI0907228B1 (pt) | 2021-08-03 |
| CA2711629C (en) | 2017-10-24 |
| RU2494103C2 (ru) | 2013-09-27 |
| JP5456694B2 (ja) | 2014-04-02 |
| US8962626B2 (en) | 2015-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0910503A2 (pt) | compostos, composições farmacêuticas e respectivos usos. | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| BRPI0908021A2 (pt) | Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica | |
| BRPI0907228A2 (pt) | Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos | |
| BRPI0918360A2 (pt) | composto, composição farmacêutica e usos de um composto | |
| BRPI1009324A2 (pt) | compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI1012892A2 (pt) | composto, e, composição farmacêutica. | |
| BRPI0820381A2 (pt) | Formulações farmacêuticas | |
| BRPI0915897A2 (pt) | compostos derivados triazóis, composições farmacêuticas e combinações dos mesmos e seus usos | |
| BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| BRPI0822337A2 (pt) | Folatos, composições e usos dos mesmos | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BR112012003842A2 (pt) | composição farmacêutica, método de formulação e uso da mesma | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| DK2285357T3 (da) | Farmaceutisk sammensætning omfattende brivaracetam | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| BRPI0915527A2 (pt) | pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/01/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |